[276 Pages Report] The global blood warmer devices market size is expected to reach a valuation of US$ 451.2 Million in 2022, and further expand at a CAGR of 7.6% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 937.5 Million by the end of 2032. Intravenous warming systems in terms of products are leading the market and it held a share of about 47.1% in 2021.
Growth in the blood warmer devices market is set to be driven by the rising prevalence of conditions like hypothermia in which the body temperature drops. Such a situation arises when the body loses heat faster than it can produce heat, and the temperature drops below 35 C. Hypothermia is generally caused due to prolonged exposure to very cold temperatures. It is also common in the neonatal period, and old age, as well as in medical conditions like dementia, hypothyroidism, and low blood sugar. Trauma patients are also highly susceptible to hypothermia.
As per the Centers for Disease Control and Prevention (CDC), from 2018 to 2020, death rates caused by hypothermia were about 0.40 per 100,000 for rural area females and 0.93 for men in rural areas. It is also predicted that the number of untracked hypothermia deaths is on the rise.
To overcome conditions of hypothermia, there are different devices used to warm the blood to minimize the risk of hypothermia, as in many instances, hypothermia can lead to abnormal functioning of the heart, nervous system, and respiratory system. Even in extreme cases, it can lead to complete failure of the heart or respiratory system. Thus, the use of blood warmers is a necessity in this aspect and so the blood warmer devices market is anticipated to grow at a rapid pace in the forecast period.
| Attributes | Key Statistics |
|---|---|
| Global Blood Warmer Devices Market Estimated Size (2022E) | US$ 451.2 Million |
| Projected Market Valuation (2032F) | US$ 937.5 Million |
| Value-based CAGR (2022 to 2032) | 7.6% |
| Collective Value Share: Top 5 Countries | 56.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Government agencies in the North American region are ordering blood warmer devices in a number of countries to provide good treatment in emergency scenarios. North America is one of the leading markets for Blood Warmer Devices products, driven largely by the USA with a total market share of about 93.3% in 2021, and a similar trend is expected over the forecast period.
In the USA, the adoption of technologically advanced products is quite higher which is why it is a dominating region. The increasing trauma cases in the USA lead to hypothermia which in turn increases the adoption of blood-warmer devices. As per LERN, Louisiana Emergency Response Network, the number of trauma cases in the USA accounts for about 37 million emergency department visits in hospitals. Hence, the sales of blood warmer devices are quite high in the USA and are anticipated to grow in the forecast period.
The presence of major industry players like 3M, BD, ICU Medical Inc., (Smith Medical, Inc.) and others are quite high in the USA market and this has also increased the availability of blood warmer devices in the USA For instance, in March 2021, MEQU, a medical technology business, won a public tender to offer portable blood warmers to the Norwegian National Air Ambulance Services. Most of the time, air ambulance services deal with crisis circumstances. Before administering to the patient, all solutions should be warmed up. Hence, ambulance services are equipped with blood warmers to facilitate this practice.
Major technological shifts in healthcare infrastructure and the rising use of advanced machinery are expected to positively affect the growth of Blood Warmer Devices production over the forecast period. The manufacturers are penetrating into various market segments by introducing Blood Warmer Devices-based products. Further, a number of international market participants are entering into acquisitions and mergers to gain a major revenue share.
For instance, in January 2022, QinFlow Inc. received a group buy agreement from Premier, Inc. for blood and fluid warming products. This arrangement will give healthcare organizations access to their next-generation blood-warming technology, which has been fine-tuned to suit the stringent requirements of emergency departments, intensive care units, operating rooms, and trauma bays. Thus, the industry is expected to grow rapidly in the coming years.
The growth of the blood warmer devices market is inclined to the prevalence of conditions like hypothermia in which the body temperature drops. The situation arises when the body loses heat faster than it can produce heat, and the temperature drops below 35 C. Hypothermia is generally caused by prolonged exposure to very cold temperatures. It is also common in the neonatal period, old age as well as in medical conditions like dementia, hypothyroidism, and low blood sugar. Trauma patients are also highly susceptible to hypothermia.
As per the Centers for Disease Control and Prevention, from 2018 to 2020, death rates caused by hypothermia were about 0.40 per 100,000 for rural area females and 0.93 for men in rural areas.
It is also predicted that the number of untracked hypothermia deaths is also on the rise. To overcome the conditions of hypothermia there are different devices used to warm the blood to minimize the risk of hypothermia because in many instances hypothermia can lead to abnormal functioning of the heart, nervous system, and respiratory system, even in extreme cases it can lead to complete failure of the heart or respiratory system. Thus the use of blood warmers is quite a necessity in this aspect and so there will be growth in the blood warmer devices market in the forecast period
Principal Consultant
The global blood warmer devices market holds approximately 5.0% of the global fluid management systems market, which was worth ~US$ 8.5 Billion in 2021. Sales in the blood warmer devices market expanded at a CAGR of 6.4% from 2017 to 2021.
The increasing neonatal and geriatric population globally is a leading driver of the blood warmer devices market. Rising cases of neonatal hypothermia are mainly attributed to the high surface area as per their body weight, less subcutaneous fat, and increased body water content. With advancing age, people lose their ability to endure long exposure to cold, which usually leads to hypothermia. This is set to positively impact the blood warmer devices market in the upcoming decade.
Technological advancements can also be considered to be a recognizable driver for this market. There are different types of blood warmers that could be useful for various medical conditions. For instance, ICU Medical, Inc. provides technologically advanced products for surgical procedures.
There are also devices such as Snuggle Warm Blankets that reduce the risk of surgical site infection and fluid warmers with air detectors that allow for quick removal of air and restoration of flow without disconnecting from the patient. Thus, technological advancement is set to lead to the wider adoption of blood-warmer devices globally. Owing to the aforementioned factors, the global blood warmer devices market is expected to grow at a CAGR of 7.6% during the forecast period from 2022 to 2032.
The global market is set to exhibit an assertive outlook owing to increased awareness about the care of hypothermia in countries where awareness is low. For instance, the Faculty of Medicine, Menoufia University, Egypt has analyzed the effect of designed guidelines on nurses′ performance to prevent hypothermia in preterm infants as hypothermia is a major factor causing neonatal death in developing countries.
Increased research and technology development, as well as rising awareness among people, would thus contribute to growth in the adoption of blood warmer devices across hospitals and clinics. These devices help to maintain one’s overall body temperature. This can be considered to be an opportunistic factor for growth in the blood warmer devices market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The cost linked with advanced blood warmer products is quite high for certain settings like home care. The individual cost is higher for low and middle-income countries. For instance, the price range in India is from 50,000 to 1, 50,000 INR per piece. These high costs, along with no reimbursement rate can hamper growth in the blood warmer devices market in certain developing countries.
Apart from this, strict regulations in various countries concerning the efficacy and safety of blood warmer devices may hamper the market to a certain extent. For instance, in September 2021, the USA Food and Drug Administration (FDA) identified blood warmer devices that possess the potential risk of aluminum leaching and instructed a voluntary recall action. Thus, the above-mentioned factors collectively propose a negative effect on growth in the blood warmer devices market.
Rising Number of Trauma Cases in the USA to Push Sales of Blood Warmer Machines
The USA dominates the North American blood warmer devices market and held a total share of about 93.3% in 2021. In the USA, the adoption of technologically advanced products is quite high, which is why it is a dominating country. An increasing number of trauma cases in the USA would lead to hypothermia, which in turn, can push the adoption of blood-warmer devices.
As per Louisiana Emergency Response Network (LERN), the number of trauma cases in the USA accounts for about 37 million emergency department visits in hospitals. Hence, sales of blood warmer devices are quite high in the USA and are anticipated to grow in the forecast period. The presence of major industry players like 3M, BD, ICU Medical Inc., (Smith Medical, Inc.), and others in the USA market has also increased the availability of blood warmer devices in the country.
Demand for Medical Fluid Warmers to Soar in the UK with Growing Cold-Related Deaths
The UK is set to hold a share of 5.1% in the global blood warmer devices market during the forecast period. In 2021, the UK held a share of about 16.3% in the Europe blood warmer devices market, finds FMI.
As per the London School of Hygiene and Tropical Medicine, in England and Wales, the number of cold-related deaths was around 60,500 between 2000 and 2019. It is mainly because of the extremely cold weather conditions in the region and accordingly, the adoption of blood-warmer devices is also increasing. Hence, the blood warmer devices market in the UK is set to be very lucrative.
Chinese Blood and Fluid Warmer Manufacturers to Offer Portable Devices by 2032
China held approximately 4.3% of the share in the global blood warmer devices market in 2021. The market is estimated to grow at a CAGR of about 8.0% in the next decade. The country is considered to be a growing market in terms of the adoption of blood warmer devices. There are several Chinese manufacturers such as Wuhan Union Medical Technology Co., Ltd, Suzhou Power Biotech Co., Ltd, and Anjue Medical Equipment Co., Ltd. providing products such as portable and hospital-use devices. This factor has contributed to the high growth of the blood warmer devices market in China.
Demand for Portable Blood Warmers and Intravenous Warming Systems to Grow by 2032
By product, the intravenous warming system segment is expected to showcase high growth at a CAGR of 7.4% by the end of the forecast period. As per FMI, the segment held a steady share of nearly 47.1% in the global blood warmer devices market in 2021.
The use of intravenous warming systems has a direct and immediate effect on the patient prior to surgery or prior to blood transfusion, and thus their utilization is more. This further helps the patient to reduce shivering and increase their overall comfort. Therefore, the intravenous warming system segment is significantly dominating in terms of products.
Medical Fluid Warmers Are to Be Extensively Used for Preoperative Care
Preoperative care accounted for a revenue share of 36.5% globally in 2021 and is expected to display a CAGR of 7.4% over the forecast period. The use of blood warmers is highest during preoperative care because the temperature of the human body generally drops during this period. There are symptoms of shivering and drops in blood pressure, which often lead to the urgent need for blood warmer devices prior to blood transfusion and surgery. Thus, preoperative care holds the highest market share in terms of application.
Hospitals and Clinics to Highly Prefer Fluid Warming Devices for Acute Care
The hospitals and clinics segment held the highest market share of 49.8% in the year 2021. The use of blood warmer devices is highest in such settings because of the increased patient flow, including preoperative cases, acute care, surgical procedures, and neonatal care. Usage is the highest in the surgery department of hospitals. Thus, the hospitals and clinics end-user segment is estimated to generate the largest market share in the forecast period.
To strengthen their presence around the globe and improve their business strategies, key players are involved in various product launches, expansions, collaborations, and mergers & acquisitions. Below are some of the key promotional strategies adopted by key players in the global blood warmer devices market:
| Attribute | Details |
|---|---|
| Estimated Market Size (2022) | US$ 451.2 Million |
| Projected Market Valuation (2032) | US$ 937.5 Million |
| Value-based CAGR (2022 to 2032) | 7.6% |
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | Value (US$ Million) |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Mexico, Brazil, Argentina, UK, Germany, Italy, France, Spain, Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC Countries, Turkey, South Africa, and North Africa. |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | 3M Company; Becton Dickinson (BD); The 37 Company; Emit Corporation; GE Healthcare; Stryker Corporation; Barkey GmbH & Co. KG; Geratherm Medical; Stihler Electronic GmbH; Belmont Instrument; Biegler GmbH; Baxter International Inc. (Gambro); Keewell Medical Technology Co. Ltd.; ICU Medical Inc. (Smiths Medical); Vyaire Medical, Inc.,; The Surgical Company; Life Warmer; MEQU; Estill Medical Technologies, Inc.; Smisson-Cartledge Biomedical |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The global blood warmer devices market was worth US$ 423.7 Million in 2021.
The blood warmer devices market is expected to reach US$ 937.5 Million by end of 2032 and grow at a CAGR of 7.6% from 2022 to 2032.
North America dominated the global blood warmer devices market, accounting for the highest share of 38.7% in 2021.
Latin America held a share of 4.2% in 2021 and exhibited growth at a CAGR of 7.5%.
The UK accounted for a share of around 16.3% in 2021 in the Europe blood warmer devices market and the country is set to showcase a lucrative CAGR of 7.5% during the forecast period.
China accounted for about 36.8% of the East Asia blood warmer devices market share in 2021 and is projected to grow at a CAGR of 8.0% in the forecast period.
The USA, the UK, Germany, China, and Japan are the top five countries, which are expected to drive demand in the blood warmer devices market.
From 2017 to 2021, the blood warmer devices market grew at a CAGR of 6.4%.
The blood warmer devices market in Japan is expected to grow at 7.9% CAGR during the forecast period.
Germany is set to witness a lucrative CAGR of 7.4% during the forecast period.
1. Executive Summary | Blood Warmer Devices Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USP Analysis
4.3. Key Strategies Adopted by Manufacturers
4.4. Regulatory Scenario
4.5. PESTLE Analysis
4.6. Porter’s Analysis
4.7. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Spending Outlook
5.1.3. Global Medical Devices Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Players Historical Growth
5.2.2. Technological Advancements
5.2.3. Increased Growth Strategies of Top Players
5.2.4. Regulatory Landscape
5.2.5. Product Setup Cost
5.2.6. Product Adoption
5.2.7. Increase in Research and Development
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application
6.1.3. By End User
6.1.4. By Region
6.2. 2021 Market Scenario
7. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Volume (Units) Analysis, 2017 to 2021
7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis by Product
8.2. Pricing Break Up
8.2.1. Manufacturer Level
8.2.2. Distributor Level
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032
9.1. Historical Market Value (US$ Million) Analysis 2017 to 2021
9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Product, 2017 to 2021
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Product, 2022 to 2032
10.3.1. Intravenous Warming System
10.3.2. Surface Warming System
10.3.3. Blood Warming Accessories
10.4. Market Attractiveness Analysis by Product
11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Application, 2017 to 2021
11.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Application, 2022 to 2032
11.3.1. Preoperative Care
11.3.2. Home Care
11.3.3. Acute Care
11.3.4. New Born Care
11.3.5. Others
11.4. Market Attractiveness Analysis by Application
12. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by End User, 2017 to 2021
12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by End User, 2022 to 2032
12.3.1. Hospitals and Clinics
12.3.2. Ambulatory Services
12.3.3. Blood Banks
12.3.4. Home care settings
12.3.5. Others
12.4. Market Attractiveness Analysis by End User
13. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis by Region, 2017 to 2021
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Region, 2022 to 2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East & Africa
13.4. Market Attractiveness Analysis by Region
14. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2021
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032
14.3.1. By Country
14.3.1.1. United States of America
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Product
14.4.2. By Application
14.4.3. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country-Level Analysis & Forecast
14.8.1. USA Market
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Application
14.8.1.2.3. By End User
14.8.2. Canada Market
14.8.3. Introduction
14.8.4. Market Analysis and Forecast by Market Taxonomy
14.8.4.1.1. By Product
14.8.4.1.2. By Application
14.8.4.1.3. By End User
15. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2021
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032
15.3.1. By Country
15.3.1.1. Mexico
15.3.1.2. Brazil
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Product
15.4.2. By Application
15.4.3. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country-Level Analysis & Forecast
15.8.1. Mexico Market
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application
15.8.1.2.3. By End User
15.8.2. Brazil Market
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Application
15.8.2.2.3. By End User
15.8.3. Argentina Market
15.8.4. Introduction
15.8.5. Market Analysis and Forecast by Market Taxonomy
15.8.5.1.1. By Product
15.8.5.1.2. By Application
15.8.5.1.3. By End User
16. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2021
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032
16.3.1. By Country
16.3.1.1. United Kingdom
16.3.1.2. Germany
16.3.1.3. Italy
16.3.1.4. France
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. BENELUX
16.3.1.8. Rest of Europe
16.3.2. By Product
16.4. Market Attractiveness Analysis
16.4.1. By Product
16.4.2. By Application
16.4.3. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country-Level Analysis & Forecast
16.8.1. UK Market
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application
16.8.1.2.3. By End User
16.8.2. Germany Market
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application
16.8.2.2.3. By End User
16.8.3. Italy Market
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Application
16.8.3.2.3. By End User
16.8.4. France Market
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Application
16.8.4.2.3. By End User
16.8.5. Spain Market
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast by Market Taxonomy
16.8.5.2.1. By Product
16.8.5.2.2. By Application
16.8.5.2.3. By End User
16.8.6. Benelux Market
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast by Market Taxonomy
16.8.6.2.1. By Product
16.8.6.2.2. By Application
16.8.6.2.3. By End User
16.8.7. Russia Market
16.8.7.1. Introduction
16.8.7.2. Market Analysis and Forecast by Market Taxonomy
16.8.7.2.1. By Product
16.8.7.2.2. By Application
16.8.7.2.3. By End User
17. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2021
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Product
17.4.2. By Application
17.4.3. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country-Level Analysis & Forecast
17.8.1. China Market
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Application
17.8.1.2.3. By End User
17.8.2. Japan Market
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Application
17.8.2.2.3. By End User
17.8.3. South Korea Market
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Application
17.8.3.2.3. By End User
18. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2021
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Indonesia
18.3.1.3. Malaysia
18.3.1.4. Thailand
18.3.1.5. Rest of South Asia
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Product
18.4.2. By Application
18.4.3. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country-Level Analysis & Forecast
18.8.1. India Market
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Application
18.8.1.2.3. By End User
18.8.2. Indonesia Market
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Application
18.8.2.2.3. By End User
18.8.3. Malaysia Market
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Application
18.8.3.2.3. By End User
18.8.4. Thailand Market
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Application
18.8.4.2.3. By End User
19. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2021
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Product
19.4.2. By Application
19.4.3. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country-Level Analysis & Forecast
19.8.1. Australia Market
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Application
19.8.1.2.3. By End User
19.8.2. New Zealand Market
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Application
19.8.2.2.3. By End User
20. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2021
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. North Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Application
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Product
20.4.2. By Application
20.4.3. By End User
20.5. Market Trends
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
20.8. Country-Level Analysis & Forecast
20.8.1. GCC Countries Market
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Application
20.8.1.2.3. By End User
20.8.2. Turkey Market
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Application
20.8.2.2.3. By End User
20.8.3. South Africa Market
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast by Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By Application
20.8.3.2.3. By End User
20.8.4. North Africa Market
20.8.4.1. Introduction
20.8.4.2. Market Analysis and Forecast by Market Taxonomy
20.8.4.2.1. By Product
20.8.4.2.2. By Application
20.8.4.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. Regional Footprint by Players
21.3.2. Product Footprint by Players
21.3.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. 3M Company
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. Key Financials
22.3.1.5. SWOT Analysis
22.3.1.6. Strategy Overview
22.3.1.6.1. Marketing Strategy
22.3.1.6.2. Product Strategy
22.3.1.6.3. Channel Strategy
22.3.2. 3M Company
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. Key Financials
22.3.2.5. SWOT Analysis
22.3.2.6. Strategy Overview
22.3.2.6.1. Marketing Strategy
22.3.2.6.2. Product Strategy
22.3.2.6.3. Channel Strategy
22.3.3. BD
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. Key Financials
22.3.3.5. SWOT Analysis
22.3.3.6. Strategy Overview
22.3.3.6.1. Marketing Strategy
22.3.3.6.2. Product Strategy
22.3.3.6.3. Channel Strategy
22.3.4. The 37 Company
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. Key Financials
22.3.4.5. SWOT Analysis
22.3.4.6. Strategy Overview
22.3.4.6.1. Marketing Strategy
22.3.4.6.2. Product Strategy
22.3.4.6.3. Channel Strategy
22.3.5. Emit Corporation
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. Key Financials
22.3.5.5. SWOT Analysis
22.3.5.6. Strategy Overview
22.3.5.6.1. Marketing Strategy
22.3.5.6.2. Product Strategy
22.3.5.6.3. Channel Strategy
22.3.6. GE Healthcare
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. Key Financials
22.3.6.5. SWOT Analysis
22.3.6.6. Strategy Overview
22.3.6.6.1. Marketing Strategy
22.3.6.6.2. Product Strategy
22.3.6.6.3. Channel Strategy
22.3.7. Stryker Corporation
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. Key Financials
22.3.7.5. SWOT Analysis
22.3.7.6. Strategy Overview
22.3.7.6.1. Marketing Strategy
22.3.7.6.2. Product Strategy
22.3.7.6.3. Channel Strategy
22.3.8. Barkey GmbH & Co. KG
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. Key Financials
22.3.8.5. SWOT Analysis
22.3.8.6. Strategy Overview
22.3.8.6.1. Marketing Strategy
22.3.8.6.2. Product Strategy
22.3.8.6.3. Channel Strategy
22.3.9. Geratherm Medical
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. Key Financials
22.3.9.5. SWOT Analysis
22.3.9.6. Strategy Overview
22.3.9.6.1. Marketing Strategy
22.3.9.6.2. Product Strategy
22.3.9.6.3. Channel Strategy
22.3.10. Stihler Electronic GmbH
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. Key Financials
22.3.10.5. SWOT Analysis
22.3.10.6. Strategy Overview
22.3.10.6.1. Marketing Strategy
22.3.10.6.2. Product Strategy
22.3.10.6.3. Channel Strategy
22.3.11. Belmont Instrument
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Sales Footprint
22.3.11.4. Key Financials
22.3.11.5. SWOT Analysis
22.3.11.6. Strategy Overview
22.3.11.6.1. Marketing Strategy
22.3.11.6.2. Product Strategy
22.3.11.6.3. Channel Strategy
22.3.12. Biegler GmbH
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Sales Footprint
22.3.12.4. Key Financials
22.3.12.5. SWOT Analysis
22.3.12.6. Strategy Overview
22.3.12.6.1. Marketing Strategy
22.3.12.6.2. Product Strategy
22.3.12.6.3. Channel Strategy
22.3.13. Baxter International Inc. (Gambro)
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Sales Footprint
22.3.13.4. Key Financials
22.3.13.5. SWOT Analysis
22.3.13.6. Strategy Overview
22.3.13.6.1. Marketing Strategy
22.3.13.6.2. Product Strategy
22.3.13.6.3. Channel Strategy
22.3.14. Keewell Medical Technology Co. Ltd.
22.3.14.1. Overview
22.3.14.2. Product Portfolio
22.3.14.3. Sales Footprint
22.3.14.4. Key Financials
22.3.14.5. SWOT Analysis
22.3.14.6. Strategy Overview
22.3.14.6.1. Marketing Strategy
22.3.14.6.2. Product Strategy
22.3.14.6.3. Channel Strategy
22.3.15. ICU Medical Inc. (Smiths Medical)
22.3.15.1. Overview
22.3.15.2. Product Portfolio
22.3.15.3. Sales Footprint
22.3.15.4. Key Financials
22.3.15.5. SWOT Analysis
22.3.15.6. Strategy Overview
22.3.15.6.1. Marketing Strategy
22.3.15.6.2. Product Strategy
22.3.15.6.3. Channel Strategy
22.3.16. Vyaire Medical, Inc.,
22.3.16.1. Overview
22.3.16.2. Product Portfolio
22.3.16.3. Sales Footprint
22.3.16.4. Key Financials
22.3.16.5. SWOT Analysis
22.3.16.6. Strategy Overview
22.3.16.6.1. Marketing Strategy
22.3.16.6.2. Product Strategy
22.3.16.6.3. Channel Strategy
22.3.17. The Surgical Company
22.3.17.1. Overview
22.3.17.2. Product Portfolio
22.3.17.3. Sales Footprint
22.3.17.4. Key Financials
22.3.17.5. SWOT Analysis
22.3.17.6. Strategy Overview
22.3.17.6.1. Marketing Strategy
22.3.17.6.2. Product Strategy
22.3.17.6.3. Channel Strategy
22.3.18. Life Warmer
22.3.18.1. Overview
22.3.18.2. Product Portfolio
22.3.18.3. Sales Footprint
22.3.18.4. Key Financials
22.3.18.5. SWOT Analysis
22.3.18.6. Strategy Overview
22.3.18.6.1. Marketing Strategy
22.3.18.6.2. Product Strategy
22.3.18.6.3. Channel Strategy
22.3.19. MEQU
22.3.19.1. Overview
22.3.19.2. Product Portfolio
22.3.19.3. Sales Footprint
22.3.19.4. Key Financials
22.3.19.5. SWOT Analysis
22.3.19.6. Strategy Overview
22.3.19.6.1. Marketing Strategy
22.3.19.6.2. Product Strategy
22.3.19.6.3. Channel Strategy
22.3.20. Estill Medical Technologies, Inc.
22.3.20.1. Overview
22.3.20.2. Product Portfolio
22.3.20.3. Sales Footprint
22.3.20.4. Key Financials
22.3.20.5. SWOT Analysis
22.3.20.6. Strategy Overview
22.3.20.6.1. Marketing Strategy
22.3.20.6.2. Product Strategy
22.3.20.6.3. Channel Strategy
22.3.21. Smisson-Cartledge Biomedical
22.3.21.1. Overview
22.3.21.2. Product Portfolio
22.3.21.3. Sales Footprint
22.3.21.4. Key Financials
22.3.21.5. SWOT Analysis
22.3.21.6. Strategy Overview
22.3.21.6.1. Marketing Strategy
22.3.21.6.2. Product Strategy
22.3.21.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Blood Warmer Devices Market
